Proteome Sciences (LSE:PRM) Short-Term Capital Lease Obligation : £0.61 Mil (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Proteome Sciences Short-Term Capital Lease Obligation?

Proteome Sciences's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.61 Mil.

Proteome Sciences's quarterly Short-Term Capital Lease Obligation declined from Dec. 2022 (£0.30 Mil) to Jun. 2023 (£0.28 Mil) but then increased from Jun. 2023 (£0.28 Mil) to Dec. 2023 (£0.61 Mil).

Proteome Sciences's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (£0.26 Mil) to Dec. 2022 (£0.30 Mil) and increased from Dec. 2022 (£0.30 Mil) to Dec. 2023 (£0.61 Mil).

Proteome Sciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Proteome Sciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteome Sciences Short-Term Capital Lease Obligation Chart

Proteome Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.58

0.13

0.26

0.30

0.61

Proteome Sciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.26	0.21	0.30	0.28	0.61

Proteome Sciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Proteome Sciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Proteome Sciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Proteome Sciences (LSE:PRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Proteome Sciences PLC (LSE:PRM) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

PMSNF:USA PRM.GB:UK

Address

Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP

Website

https://www.proteomics.com

Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product. Geographically, it has a presence in the United States, the United Kingdom, and the European Union.